Lee Curtis
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Optimized Infliximab Induction Predicts Better Long-Term Clinical and Biomarker Outcomes Compared to Standard Induction Dosing.
Journal: Journal of pediatric gastroenterology and nutrition
Published: September 01, 2022
Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
Journal: Journal of pediatric gastroenterology and nutrition
Published: June 06, 2021
Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic.
Journal: BMJ open gastroenterology
Published: February 16, 2021
Ferric Carboxymaltose Across All Ages in Paediatric Gastroenterology Shows Efficacy Without Increased Safety Concerns.
Journal: Journal of pediatric gastroenterology and nutrition
Published: November 24, 2020
A Decade of Varicella Screening Within a Paediatric Inflammatory Bowel Disease Population.
Journal: Journal of Crohn's & colitis
Published: January 01, 2020
Prehabilitation: The Impact of Preoperative Exclusive Enteral Nutrition on Paediatric Patients With Crohn Disease.
Journal: Journal of pediatric gastroenterology and nutrition
Published: December 28, 2019
Using a Steroid-sparing Tool in Paediatric Inflammatory Bowel Disease to Evaluate Steroid Use and Dependency.
Journal: Journal of pediatric gastroenterology and nutrition
Published: August 23, 2019
The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction.
Journal: Alimentary pharmacology & therapeutics
Published: May 22, 2019
Severe hypophosphataemia following ferric carboxymaltose infusion in paediatric patients with inflammatory bowel disease.
Journal: Frontline gastroenterology
Published: April 02, 2019
Skin staining due to intravenous iron extravasation in a teenager with Crohn's disease.
Journal: Archives of disease in childhood
Published: December 02, 2018
Switching From Originator to Biosimilar Infliximab in Paediatric Inflammatory Bowel Disease Is Feasible and Uneventful.
Journal: Journal of pediatric gastroenterology and nutrition
Published: July 10, 2018
Last Updated: 09/26/2026